Sylvia Mahara

832 citations
9 papers · 658 indexed · h-index 8
    • Cancer, Hypoxia, and Metabolism 2
    • Epigenetics and DNA Methylation 4
    • RNA modifications and cancer 2
    • CRISPR and Genetic Engineering 2
    • Histone Deacetylase Inhibitors Research 2
    • Protein Tyrosine Phosphatases 2
    • Single-cell and spatial transcriptomics 1
    • Acute Myeloid Leukemia Research 1

Sylvia Mahara

9 papers receiving 654 citations

Peers

Sylvia Mahara
Comparison fields: 5 of 70
  • Cancer Research 179
  • Oncology 210
  • Molecular Biology 502
  • Hematology 65
  • Immunology 80
Replace Liangxian Cao with:
Liangxian Cao United States
Adrian P. Rybak Canada
Keyi Zhu United States
Gina M. Ney United States
Ján Gurský Czechia
S Hoffarth Germany
Joseph Clara United States
Shikha Saini United States
Nicole E. McNeil United States
Melissa M. Wolf United States
Sylvia Mahara relative to Liangxian Cao United States Liangxian Cao's profile →
Citations per field
00.5×3.8×
Liangxian Cao · 1×
Citations per year

Countries citing papers authored by Sylvia Mahara

Since Specialization
Citations

This map shows the geographic impact of Sylvia Mahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Mahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Mahara more than expected).

Fields of papers citing papers by Sylvia Mahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Mahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Mahara. The network helps show where Sylvia Mahara may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sylvia Mahara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvia Mahara Line = papers co-authored together Sylvia Mahara links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20241
2 202324
3 202121
4 202140
5 2018232
6 201670
7 201230
8 201158
9 2011182

About Sylvia Mahara

Sylvia Mahara is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 9 papers that have together received 658 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Protein Tyrosine Phosphatases (2 papers), Acute Myeloid Leukemia Research (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Cancer Research (179 citations), Oncology (210 citations) and Molecular Biology (502 citations). Sylvia Mahara has collaborated with scholars based in Singapore, Australia and China. Frequent co-authors include Qiang Yu, Wee Joo Chng, Chonglei Bi, Jianbiao Zhou, Puay Leng Lee, Min Feng, Bao Yi, Gokce Oguz, Xiaojian Wu and Sau Shung Fong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026